Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TOFACITINIB Cause Hepatitis? 505 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 505 reports of Hepatitis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.

505
Reports of Hepatitis with TOFACITINIB
0.3%
of all TOFACITINIB reports
251
Deaths
362
Hospitalizations

How Dangerous Is Hepatitis From TOFACITINIB?

Of the 505 reports, 251 (49.7%) resulted in death, 362 (71.7%) required hospitalization, and 265 (52.5%) were considered life-threatening.

Is Hepatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 505 reports have been filed with the FAERS database.

What Other Side Effects Does TOFACITINIB Cause?

Drug ineffective (30,382) Pain (21,659) Condition aggravated (16,925) Arthralgia (15,640) Fatigue (13,551) Rheumatoid arthritis (12,277) Off label use (11,736) Headache (11,061) Joint swelling (10,686) Malaise (9,040)

What Other Drugs Cause Hepatitis?

METHOTREXATE (1,835) ACETAMINOPHEN (1,450) TOCILIZUMAB (1,184) HYDROXYCHLOROQUINE (1,133) ADALIMUMAB (1,096) RITUXIMAB (1,017) ETANERCEPT (1,013) LEFLUNOMIDE (997) PEMBROLIZUMAB (935) NIVOLUMAB (930)

Which TOFACITINIB Alternatives Have Lower Hepatitis Risk?

TOFACITINIB vs TOFERSEN TOFACITINIB vs TOLNAFTATE TOFACITINIB vs TOLODODEKIN ALFA TOFACITINIB vs TOLTERODINE TOFACITINIB vs TOLVAPTAN

Related Pages

TOFACITINIB Full Profile All Hepatitis Reports All Drugs Causing Hepatitis TOFACITINIB Demographics